Showing 1 - 20 results of 30 for search 'Pär-Ola Bendahl', query time: 0.05s Refine Results
  1. 1
    Longitudinal Assessment of Circulating Tumor Cells and Outcome in Small Cell Lung Cancer: A Sub-Study of RASTEN—A Randomized Trial with Low Molecular Weight Heparin

    Longitudinal Assessment of Circulating Tumor Cells and Outcome in Small Cell Lung Cancer: A Sub-Study of RASTEN—A Randomized Trial with Low Molecular Weight Heparin by Pär-Ola Bendahl, Mattias Belting, Emelie Gezelius

    Published 2023-06-01
    Get full text
    Article
  2. 2
    Protein array profiling of circulating angiogenesis-related factors during bevacizumab containing treatment in metastatic colorectal cancer.

    Protein array profiling of circulating angiogenesis-related factors during bevacizumab containing treatment in metastatic colorectal cancer. by Helga Hagman, Pär-Ola Bendahl, Jon Lidfeldt, Mattias Belting, Anders Johnsson

    Published 2018-01-01
    Get full text
    Article
  3. 3
    Artificial neural network models to predict nodal status in clinically node-negative breast cancer

    Artificial neural network models to predict nodal status in clinically node-negative breast cancer by Looket Dihge, Mattias Ohlsson, Patrik Edén, Pär-Ola Bendahl, Lisa Rydén

    Published 2019-06-01
    Get full text
    Article
  4. 4
    High CYP27A1 expression is a biomarker of favorable prognosis in premenopausal patients with estrogen receptor positive primary breast cancer

    High CYP27A1 expression is a biomarker of favorable prognosis in premenopausal patients with estrogen receptor positive primary breast cancer by Maria Inasu, Pär-Ola Bendahl, Mårten Fernö, Per Malmström, Signe Borgquist, Siker Kimbung

    Published 2021-09-01
    Get full text
    Article
  5. 5
    Prior Adjuvant Tamoxifen Treatment in Breast Cancer Is Linked to Increased AIB1 and HER2 Expression in Metachronous Contralateral Breast Cancer.

    Prior Adjuvant Tamoxifen Treatment in Breast Cancer Is Linked to Increased AIB1 and HER2 Expression in Metachronous Contralateral Breast Cancer. by Sara Alkner, Pär-Ola Bendahl, Anna Ehinger, Kristina Lövgren, Lisa Rydén, Mårten Fernö

    Published 2016-01-01
    Get full text
    Article
  6. 6
    Protease Activated Receptors 1 and 2 Correlate Differently with Breast Cancer Aggressiveness Depending on Tumor ER Status.

    Protease Activated Receptors 1 and 2 Correlate Differently with Breast Cancer Aggressiveness Depending on Tumor ER Status. by Jon Lidfeldt, Pär-Ola Bendahl, Carina Forsare, Per Malmström, Mårten Fernö, Mattias Belting

    Published 2015-01-01
    Get full text
    Article
  7. 7
    Psychological Resilience and Health-Related Quality of Life in 418 Swedish Women with Primary Breast Cancer: Results from a Prospective Longitudinal Study

    Psychological Resilience and Health-Related Quality of Life in 418 Swedish Women with Primary Breast Cancer: Results from a Prospective Longitudinal Study by Åsa Mohlin, Pär-Ola Bendahl, Cecilia Hegardt, Corinna Richter, Ingalill Rahm Hallberg, Lisa Rydén

    Published 2021-05-01
    Get full text
    Article
  8. 8
    Co-localization of CD169+ macrophages and cancer cells in lymph node metastases of breast cancer patients is linked to improved prognosis and PDL1 expression

    Co-localization of CD169+ macrophages and cancer cells in lymph node metastases of breast cancer patients is linked to improved prognosis and PDL1 expression by Frida Björk Gunnarsdottir, Nathalie Auoja, Pär-Ola Bendahl, Lisa Rydén, Mårten Fernö, Karin Leandersson

    Published 2020-01-01
    Get full text
    Article
  9. 9
    Retrospective validation study of an artificial neural network-based preoperative decision-support tool for noninvasive lymph node staging (NILS) in women with primary breast cancer (ISRCTN14341750)

    Retrospective validation study of an artificial neural network-based preoperative decision-support tool for noninvasive lymph node staging (NILS) in women with primary breast cance... by Ida Skarping, Julia Ellbrant, Looket Dihge, Mattias Ohlsson, Linnea Huss, Pär-Ola Bendahl, Lisa Rydén

    Published 2024-01-01
    Get full text
    Article
  10. 10
    The NILS Study Protocol: A Retrospective Validation Study of an Artificial Neural Network Based Preoperative Decision-Making Tool for Noninvasive Lymph Node Staging in Women with Primary Breast Cancer (ISRCTN14341750)

    The NILS Study Protocol: A Retrospective Validation Study of an Artificial Neural Network Based Preoperative Decision-Making Tool for Noninvasive Lymph Node Staging in Women with P... by Ida Skarping, Looket Dihge, Pär-Ola Bendahl, Linnea Huss, Julia Ellbrant, Mattias Ohlsson, Lisa Rydén

    Published 2022-02-01
    Get full text
    Article
  11. 11
    Noninvasive Staging of Lymph Node Status in Breast Cancer Using Machine Learning: External Validation and Further Model Development

    Noninvasive Staging of Lymph Node Status in Breast Cancer Using Machine Learning: External Validation and Further Model Development by Malin Hjärtström, Looket Dihge, Pär-Ola Bendahl, Ida Skarping, Julia Ellbrant, Mattias Ohlsson, Lisa Rydén

    Published 2023-11-01
    Get full text
    Article
  12. 12
    Gene expression in metastatic breast cancer—patterns in primary tumors and metastatic tissue with prognostic potential

    Gene expression in metastatic breast cancer—patterns in primary tumors and metastatic tissue with prognostic potential by Julia Tutzauer, Anna-Maria Larsson, Kristina Aaltonen, Caroline Bergenfelz, Pär-Ola Bendahl, Lisa Rydén, Lisa Rydén

    Published 2024-02-01
    Get full text
    Article
  13. 13
    CA 19-9 and CA 125 as potential predictors of disease recurrence in resectable lung adenocarcinoma.

    CA 19-9 and CA 125 as potential predictors of disease recurrence in resectable lung adenocarcinoma. by Sofi Isaksson, Per Jönsson, Nastaran Monsef, Hans Brunnström, Pär-Ola Bendahl, Mats Jönsson, Johan Staaf, Maria Planck

    Published 2017-01-01
    Get full text
    Article
  14. 14
    Serum immuno-oncology markers carry independent prognostic information in patients with newly diagnosed metastatic breast cancer, from a prospective observational study

    Serum immuno-oncology markers carry independent prognostic information in patients with newly diagnosed metastatic breast cancer, from a prospective observational study by Frida Björk Gunnarsdottir, Pär-Ola Bendahl, Alexandra Johansson, Rui Benfeitas, Lisa Rydén, Caroline Bergenfelz, Anna-Maria Larsson

    Published 2023-03-01
    Get full text
    Article
  15. 15
    Plasma membrane expression of G protein-coupled estrogen receptor (GPER)/G protein-coupled receptor 30 (GPR30) is associated with worse outcome in metachronous contralateral breast cancer.

    Plasma membrane expression of G protein-coupled estrogen receptor (GPER)/G protein-coupled receptor 30 (GPR30) is associated with worse outcome in metachronous contralateral breast... by Julia Tutzauer, Martin Sjöström, Pär-Ola Bendahl, Lisa Rydén, Mårten Fernö, L M Fredrik Leeb-Lundberg, Sara Alkner

    Published 2020-01-01
    Get full text
    Article
  16. 16
    The implementation of NILS: A web-based artificial neural network decision support tool for noninvasive lymph node staging in breast cancer

    The implementation of NILS: A web-based artificial neural network decision support tool for noninvasive lymph node staging in breast cancer by Looket Dihge, Looket Dihge, Pär-Ola Bendahl, Ida Skarping, Ida Skarping, Malin Hjärtström, Mattias Ohlsson, Lisa Rydén, Lisa Rydén

    Published 2023-03-01
    Get full text
    Article
  17. 17
    PAM50 Intrinsic Subtype Profiles in Primary and Metastatic Breast Cancer Show a Significant Shift toward More Aggressive Subtypes with Prognostic Implications

    PAM50 Intrinsic Subtype Profiles in Primary and Metastatic Breast Cancer Show a Significant Shift toward More Aggressive Subtypes with Prognostic Implications by Charlotte Levin Tykjær Jørgensen, Anna-Maria Larsson, Carina Forsare, Kristina Aaltonen, Sara Jansson, Rachel Bradshaw, Pär-Ola Bendahl, Lisa Rydén

    Published 2021-03-01
    Get full text
    Article
  18. 18
    The Distribution of Circulating Tumor Cells Is Different in Metastatic Lobular Compared to Ductal Carcinoma of the Breast—Long-Term Prognostic Significance

    The Distribution of Circulating Tumor Cells Is Different in Metastatic Lobular Compared to Ductal Carcinoma of the Breast—Long-Term Prognostic Significance by Ulrik Narbe, Pär-Ola Bendahl, Kristina Aaltonen, Mårten Fernö, Carina Forsare, Charlotte Levin Tykjær Jørgensen, Anna-Maria Larsson, Lisa Rydén

    Published 2020-07-01
    Get full text
    Article
  19. 19
    Evolution of Estrogen Receptor Status from Primary Tumors to Metastasis and Serially Collected Circulating Tumor Cells

    Evolution of Estrogen Receptor Status from Primary Tumors to Metastasis and Serially Collected Circulating Tumor Cells by Carina Forsare, Pär-Ola Bendahl, Eric Moberg, Charlotte Levin Tykjær Jørgensen, Sara Jansson, Anna-Maria Larsson, Kristina Aaltonen, Lisa Rydén

    Published 2020-04-01
    Get full text
    Article
  20. 20
    Circulating Levels of the Cardiovascular Biomarkers ST2 and Adrenomedullin Predict Outcome within a Randomized Phase III Lung Cancer Trial (RASTEN)

    Circulating Levels of the Cardiovascular Biomarkers ST2 and Adrenomedullin Predict Outcome within a Randomized Phase III Lung Cancer Trial (RASTEN) by Emelie Gezelius, Pär-Ola Bendahl, Widet Gallo, Kelin Gonçalves de Oliveira, Lars Ek, Bengt Bergman, Jan Sundberg, Olle Melander, Mattias Belting

    Published 2022-03-01
    Get full text
    Article

Search Tools: